Health

NASA/CXC/MIT/
F.K.Baganoff et al.


China's Hepatitis B market to double by 2012   " ... Decision Resources puts the current count of people in China with chronic hepatitis B at 80 million, though other reports estimate the total is 50% higher – 120 million. That constitutes almost 10% of the population. Part of the reason behind the high dollar value of drugs for this population is that the nucleoside/nucleotide analogue class of drugs often used to treat the disease must be given long term, often for the rest of a patient’s life. In most cases, these drugs are effective, suppressing the viral count, but the disease reappears as soon as treatment is discontinued ..." seekingalpha.com (site accessed Sep 2008)

USA: Nutritional supplements to reach $8.5 billion in 2012   " ... Helping to protect the category as consumers tighten their discretionary spending belts are the strong preventive health care angle of supplements and the market’s sizeable component of better-off demographics including aging Baby Boomers. Nutritional Supplements in the U.S. reports on numerous other positive factors also at play, including industry efforts to promote supplements as more essential than ever in weak economic times since they can help to avert the need for much costlier prescription drugs and medical treatments ..." packagedfacts.com (site accessed Aug 08)

Global market for cancer drugs expected to exceed $78 billion by 2012   " ... Cancer vaccines and antiangiogenics will record the fastest growth rate between 2007 and 2012 ..." researchandmarkets.com (site accessed Aug 2008)
See also: $8 billion dollar cancer vaccine market by 2012   " ... As many as five new vaccines to treat cancer may soon be available, creating an $8 billion dollar cancer vaccine market by 2012, representing over half of the $15 billion total vaccine market that will exist that year, according to (market research firm) Kalorama. ...." Earthtimes.org (site accessed Feb 2007)
See also: Global Market for Cancer Immunotherapy Worth $37.2 Billion by 2012 Pharmalive.com (site accessed Mar 2007)

Europe: Obesity to hit one third of kids by 2012   "Over a third of children aged five to 13 will be overweight or obese by 2012, according to a report published today (7 July) by research analysts Datamonitor ... Datamonitor blamed above-average consumption of "energy-dense, indulgence food and drinks", including savoury snacks and ice cream. The analysts also pointed to non-food factors including lack of exercise and the importance of travelling by car to out-of-town retail parks and leisure venues ..." just-food.com (site accessed July 2008)

Gastrointestinal disorders in 2012   "Gastrointestinal (GI) disorders are set to affect over 250 million people in the seven largest pharma markets, by 2012. As generations of people become more obese and consume increasingly poor diets then so too will the number of people suffering from these disorders rise ... " expertdoctor.blogspot.com (site accessed Sep 2007)

Global epigenomics market to reach $4.1 billion by 2012  "$4.1 Billion by 2012? is the major finding of a market report on the global epigenomics market published by BCC Research. The report identified three key market segments that will be commercially important in the field of epigenomics in the next 5 years: research tools, cancer diagnostics, and cancer therapeutics." www.epigeneticsnews.com (site accessed May 2007)

HIV experts say 20 million in Asia could be infected by 2012   "The number of people in Asia with the AIDS virus may more than double over the next five years unless governments do more to stop the spread of HIV, officials said yesterday. About 8.6-million people in Asia are infected with HIV..." The Calgary Sun (site accessed Apr 2007)

500,000 people in Uganda to be targeted for routine AIDS testing and counselling by 2012   "... Currently, there are an estimated 1.1 million HIV infected individuals and this number is projected to increase to 1.8 million by 2012 at the current rate of of 135,000 new infections annually ...” NewVision.co.ug (site accessed Jan 2007)

South Korea will start to use human embryonic stem cells in actual therapy around 2012   "The first target will be hard-to-cure diseases caused by nerve cell disorders as scientists are continuing to make breakthroughs in the field'' The Korea Times (site accessed Sept 2006)

NHS Computer system to link general practitioners (GPs) in England to nearly 300 hospitals by 2012   "It involves an online booking system, a centralised medical records system for 50m patients, e-prescriptions and fast computer network links between NHS organisations ....senior academics question whether the National Programme for IT has been properly designed and rigorously reviewed to meet the needs of 24-hour health care." BBC News (site accessed June 2006)

Worldwide homecare systems expected to reach $1.2 billion by 2012 "The homecare market is changing. New services needed in the home include intravenous (IV) therapy, pain control, and basic needs services delivery. Delivery of new services depends on systems integration." Genetic Engineering News (site accessed May 2006)

Transgenically Produced Biopharmaceuticals Could Soar to $12 Billion by 2012
"With the possibility of the world’s first transgenic plant-produced biopharmaceutical being approved for use this year, worldwide attention is focusing on the futuristic breakthroughs that could dramatically alter the biopharm manufacturing landscape and drive sales past the $12 billion mark by 2012, according to a new study from market research firm Kalorama Information, a division of MarketResearch.com, a leading provider of industry-specific market research reports." PR Leap (site accessed Feb 2006)

China vows to eliminate measles by 2012   "China is drafting an action plan for measles control for the next few years which aims to eliminate measles by 2012." China View (site accessed Mar 2006)
See also: The Chinese government has drawn up a 5 yr action plan to eliminate measles. China View (site accessed Dec 2006)

top